Parhizkar, Samira http://orcid.org/0000-0001-5807-190X
Arzberger, Thomas
Brendel, Matthias
Kleinberger, Gernot
Deussing, Maximilian
Focke, Carola
Nuscher, Brigitte
Xiong, Monica http://orcid.org/0000-0002-8398-1814
Ghasemigharagoz, Alireza
Katzmarski, Natalie
Krasemann, Susanne
Lichtenthaler, Stefan F.
Müller, Stephan A.
Colombo, Alessio
Monasor, Laura Sebastian
Tahirovic, Sabina http://orcid.org/0000-0003-4403-9559
Herms, Jochen
Willem, Michael
Pettkus, Nadine
Butovsky, Oleg
Bartenstein, Peter
Edbauer, Dieter http://orcid.org/0000-0002-7186-4653
Rominger, Axel
Ertürk, Ali http://orcid.org/0000-0001-5163-5100
Grathwohl, Stefan A.
Neher, Jonas J. http://orcid.org/0000-0003-1346-8924
Holtzman, David M.
Meyer-Luehmann, Melanie http://orcid.org/0000-0003-3661-2220
Haass, Christian http://orcid.org/0000-0002-4869-1627
Article History
Received: 19 January 2018
Accepted: 14 November 2018
First Online: 7 January 2019
Competing interests
: C.H. collaborates with Denali and received a speaker honorarium of Roche and Novartis. D.M.H. co-founded and is on the scientific advisory board of C2N Diagnostics. D.M.H. consults for Denali, Eli Lilly, Glaxosmithkline, and AbbVie. A.R. received consultant and speaker honoria from Piramal Imaging and GE Healthcare. O.B. collaborates with Sanofi. S.T. collaborates with Ono Pharmaceuticals (Japan). S.A.G is an employee of Neurimmune AG. All other authors declare no competing interests.